Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179680PMC

Publication Analysis

Top Keywords

off-label off-limits
4
off-limits fda
4
fda create
4
create safe
4
safe harbor
4
harbor off-label
4
off-label drug
4
off-label
2
fda
1
create
1

Similar Publications

Polyaromatic hydrocarbons (PAHs) are considered as redox active environmental toxicants inducing oxidative stress (OS) mediated injury to cells. Oxidative predominance is reported in 30%-80% of idiopathic male infertility (IMI) patients. Hence, this work aims to unravel correlation, if any, between seminal PAH exposome and sperm function in IMI patients through a proteomic approach.

View Article and Find Full Text PDF

Image-based cell classification has become a common tool to identify phenotypic changes in cell populations. However, this methodology is limited to organisms possessing well-characterized species-specific reagents (, antibodies) that allow cell identification, clustering, and convolutional neural network (CNN) training. In the absence of such reagents, the power of image-based classification has remained mostly off-limits to many research organisms.

View Article and Find Full Text PDF

Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics.

Eur J Pediatr

December 2009

Department for Medical Ethics and History of Medicine, University of Göttingen, Humboldtallee 36, 37073 Göttingen, Germany.

Off-label drug use in paediatrics is associated with an increased risk of adverse drug reactions. Any risk-benefit analysis has to be based on value judgments that should include parents' views. However, nothing is known so far about the parents' perspective on this critical issue.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!